摘要
炎症机制在冠状动脉支架术后内膜增殖和支架内再狭窄的发生、发展中扮演重要角色。近年来,实验和临床研究表明,通过检测炎症因子可预测主要不良心脏事件,针对高危患者进行合理的抗炎治疗对于改善患者的预后具有重要价值。
After coronary stenting, inflammatory mechanisms play a crucial role in the initiation and progression of neointimal proliferation and in-stent restenosis. More recently, experimental and clinic study have indicated that the detection of inflammation factors are predictive of restenosis and major adverse cardiac event. The anti-inflammatory therapy is benefit to improving the prognosis of subjects at high risk.
出处
《心血管病学进展》
CAS
2008年第B05期11-14,共4页
Advances in Cardiovascular Diseases
